Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on April 26, 2004

Circulation. 2004
Published online before print April 26, 2004, doi: 10.1161/01.CIR.0000127429.53391.78
A more recent version of this article appeared on May 4, 2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
109/17/2123    most recent
01.CIR.0000127429.53391.78v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cox, M. J.
Right arrow Articles by Tyagi, S. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cox, M. J.
Right arrow Articles by Tyagi, S. C.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Nucleotide
*Protein*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCIUM CHLORIDE
*NITRIC OXIDE
Related Collections
Right arrow Congestive
Right arrow Remodeling
Right arrow Heart failure - basic studies
Right arrow Myocardial cardiomyopathy disease

Submitted on February 3, 2003
Revised on January 20, 2004
Accepted on January 22, 2004

Attenuation of Oxidative Stress and Remodeling by Cardiac Inhibitor of Metalloproteinase Protein Transfer

Michael J. Cox MD, Urseline A. Hawkins MD, Brian D. Hoit MD, and Suresh C. Tyagi PhD*

From the Department of Physiology and Biophysics, School of Medicine, University of Louisville, Louisville, Ky (M.J.C., U.A.H., S.C.T.); and Department of Medicine, Division of Cardiology, Case Western Reserve University, Cleveland, Ohio (B.D.H.).

* To whom correspondence should be addressed. E-mail: s0tyag01{at}louisville.edu.

Background--Matrix metalloproteinase (MMP) and cardiac inhibitor of metalloproteinase (CIMP) are coexpressed in the heart. Although it is known that oxidative stress activates MMP and CIMP inhibits MMP, it is unclear whether CIMP administration attenuates oxidative stress and MMP-mediated cardiac dilatation.

Methods and Results--Arteriovenous fistula (AVF) was created in C57BL/J6 mice, and CIMP was administered to AVF and sham mice by protein transfer into peritoneal cavity by minipump for 4 weeks. Mice were grouped as follows: sham; sham+CIMP; AVF; and AVF+CIMP (n=6). In vivo left ventricular (LV) pressure was measured. Plasma and LV tissue levels of CIMP were measured by Western analysis. LV levels of NADPH oxidase activity, marker of oxidative stress, were increased in AVF mice and decreased in AVF mice treated with CIMP. Compared with sham, CIMP was decreased in AVF mice, and CIMP protein transfer increased plasma and LV tissue levels of CIMP in AVF mice; there was no increase in sham animals. In situ zymography demonstrated a robust increase in MMP activity in the hearts from AVF mice compared with sham, and treatment with CIMP decreased MMP activity. In AVF mice, the cardiac pressure-length relationship was similar to that observed in sham mice after administration of CIMP. Contractile responses of normal LV rings were measured in the presence and absence of CIMP. CIMP shifted the pressure-length relationship to the left, attenuated LV dilatation, and had no effect on CaCl2-mediated contraction.

Conclusions--Treatment of AVF mice with CIMP significantly abrogated the contractile dysfunction and decreased the oxidative stress in volume overload-induced heart failure.


Key words: proteomics • nitric oxide • NADPH oxidase • relaxation • heart failure




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
D. Vanhoutte, M. Schellings, Y. Pinto, and S. Heymans
Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: A temporal and spatial window
Cardiovasc Res, February 15, 2006; 69(3): 604 - 613.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Ichihara, A. Noda, K. Nagata, K. Obata, J. Xu, G. Ichihara, S. Oikawa, S. Kawanishi, Y. Yamada, and M. Yokota
Pravastatin increases survival and suppresses an increase in myocardial matrix metalloproteinase activity in a rat model of heart failure
Cardiovasc Res, February 15, 2006; 69(3): 726 - 735.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
N. Tyagi, K. C. Sedoris, M. Steed, A. V. Ovechkin, K. S. Moshal, and S. C. Tyagi
Mechanisms of homocysteine-induced oxidative stress
Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2649 - H2656.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
H. M. Schiotz Thorud, A. Stranda, J.-A. Birkeland, P. K. Lunde, I. Sjaastad, S. O. Kolset, O. M. Sejersted, and P. O. Iversen
Enhanced matrix metalloproteinase activity in skeletal muscles of rats with congestive heart failure
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2005; 289(2): R389 - R394.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. S. Moshal, N. Tyagi, B. Henderson, A. V. Ovechkin, and S. C. Tyagi
Protease-activated receptor and endothelial-myocyte uncoupling in chronic heart failure
Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2770 - H2777.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. A. Garcia, K. L. Brown, R. S. Pavelec, K. V. Go, J. W. Covell, and F. J. Villarreal
Abnormal cardiac wall motion and early matrix metalloproteinase activity
Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1080 - H1087.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
S. C. Tyagi, W. Rodriguez, A. M. Patel, A. M. Roberts, J. C. Falcone, J. C. Passmore, J. T. Fleming, and I. G. Joshua
Hyperhomocysteinemic Diabetic Cardiomyopathy: Oxidative Stress, Remodeling, and Endothelial-Myocyte Uncoupling
Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 2005; 10(1): 1 - 10.
[Abstract] [PDF]


Home page
Am. J. Pathol.Home page
S. Heymans, F. Lupu, S. Terclavers, B. Vanwetswinkel, J.-M. Herbert, A. Baker, D. Collen, P. Carmeliet, and L. Moons
Loss or Inhibition of uPA or MMP-9 Attenuates LV Remodeling and Dysfunction after Acute Pressure Overload in Mice
Am. J. Pathol., January 1, 2005; 166(1): 15 - 25.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. S. Ikonomidis, J. W. Hendrick, A. M. Parkhurst, A. R. Herron, P. G. Escobar, K. B. Dowdy, R. E. Stroud, E. Hapke, M. R. Zile, and F. G. Spinale
Accelerated LV remodeling after myocardial infarction in TIMP-1-deficient mice: effects of exogenous MMP inhibition
Am J Physiol Heart Circ Physiol, January 1, 2005; 288(1): H149 - H158.
[Abstract] [Full Text] [PDF]